Skip to main content
Figure 3 | Molecular Pain

Figure 3

From: Anxiolytic-like effects of translocator protein (TSPO) ligand ZBD-2 in an animal model of chronic pain

Figure 3

Effects of ZBD-2 on TSPO levels. (A) Representative results of Western blot analysis for TSPO in the BLA on the Day 21 after hindpaw CFA-injection. (B) ZBD-2 (0.15 and 1.5 mg/kg) for one week significantly decreased the upregulation of TSPO in the BLA. n = 6 in each group, **p < 0.01 compared to the control group; # p < 0.05, ## p < 0.01 compared to the CFA+ saline group.

Back to article page